Randox, a UK developer of diagnostic solutions, has added two new liquid assayed chemistry controls to its portfolio, which it believes will revolutionise quality control in medical laboratories, saving time and money while ensuring highly accurate results and patient diagnosis.
Acusera Liquid Assayed Chemistry Premium and Premium Plus, are designed to cut the number of individual quality controls (QC) a laboratory needs to run in routine medical testing. Using the Randox controls, laboratories can run QC on up to 100 analytes within one test, without compromising performance or accuracy, the firm says.
Although the concept of offering multi-analyte controls is not new, Randox claims its assayed controls are the most comprehensive to date, containing a combination of proteins, lipids, immunoassays, cardiac markers, blood markers, therapeutic drugs and routine chemistry analytes.
The Acusera Chemistry Premium Plus control contains 100 analytes, while the Acusera Chemistry Premium control offers 91, with the following features:
- The high levels of CRP and other key proteins included eliminate the need for multiple controls, streamlining QC in laboratories.
- They are assayed controls, providing clinically significant values for a range of analysers.
- Both controls are liquid, eliminating possible reconstitution errors and improving lab efficiency.
- Available in three concentration levels (low, mid and high), Premium Plus covers the full clinical range, removing the need for laboratories to purchase additional controls.
- The controls are highly stable when stored at -20 to -70°C with open vial stability of up to seven days at +2-8°C, reducing wastage in laboratories.
- They are manufactured using human-based serum, ensuring performance that closely mirrors patient samples.
The controls are now available in the UK, Europe, Middle East, Far East and Africa. Randox is currently awaiting product approval from the US FDA and China SFDA.
